Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet’s syndrome: case series and literature review

OBJECTIVES: This study aimed to investigate the efficacy and safety of tocilizumab (TCZ) in severe and refractory parenchymal neuro-Behçet’s syndrome (p-NBS). METHODS: We retrospectively analyzed five patients with p-NBS treated with TCZ in our center between 2013 and 2020, and six cases from litera...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinjing, Yan, Dong, Wang, Zhimian, Yang, Yunjiao, Zhang, Shangzhu, Wu, Di, Peng, Lingyi, Liu, Zhichun, Zheng, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675870/
https://www.ncbi.nlm.nih.gov/pubmed/33240406
http://dx.doi.org/10.1177/1759720X20971908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675870/
https://www.ncbi.nlm.nih.gov/pubmed/33240406
http://dx.doi.org/10.1177/1759720X20971908

Ejemplares similares